Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma

NCT03012061 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

425

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: UMEC
DRUG: Fluticasone Furoate
DRUG: Albuterol/salbutamol

Sponsor

GlaxoSmithKline